Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets

Report Code: HLC176E

Publish Date: Jul 2024

Publisher: BCC Publishing

Category: Health Maintenance

Download Report Overview

Single User License: $4650

Member Price: FREE

EXPLORE OFFERS

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for radiation therapy products and radiopharmaceuticals is expected to grow from $17.5 billion in 2024 and is projected to reach $31.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.3% during the forecast period of 2024 to 2029.

Report Includes

  • 51 data tables and 39 additional tables
  • An overview of the global market for radiotherapy, radiopharmaceuticals and nuclear medicines
  • Analysis of global market trends, featuring historical revenue data for 2021-2023, estimated figures for 2024, forecasts for 2025, and projected CAGRs through 2029
  • Identification of new opportunities, challenges and technological changes in the industry and a market share analysis by segment, product type, technology type, application, production method, and region
  • Examination of the present and future strategies of companies in the market, including radiopharmaceuticals for both diagnostic and therapeutic purposes
  • Discussion of the applications for positron emission tomography (PET) and single photon emission computed tomography (SPECT)
  • Evaluation of market opportunities for external beam radiation therapy, internal radiation therapy and systemic radiotherapy
  • Analysis of the current market trends and forecast, R&D activity, product launches and regulatory elements
  • Analysis of the key companies’ market shares, mergers & acquisitions, joint ventures and collaborations
  • Profiles of the major players in the market, including Accuray Inc., Cardinal Health, Elekta, Novartis AG, and Siemens Healthineers AG

Report Scope

This report analyzes the global market for radiation therapy products (systems, software and services) and radiopharmaceuticals, in terms of quantitative and qualitative data, to help readers develop assess the market, business/growth strategies, and make informed business decisions regarding radiation therapy products and services and radiopharmaceuticals. BCC Research estimates market data for 2023 (the base year) and forecasts values for 2024 through 2029.

Radiation therapy market segmentation is based on product, technology, techniques, system type, application and region. Radiopharmaceuticals market segmentation is based on product, application, production method and region.

Industry growth drivers, restraints and opportunities in the radiation therapy and radiopharmaceutical market are also discussed. The report also reports on the competitive landscape of radiation therapy products, radiopharmaceutical markets and emerging trends. The latest new products, acquisitions, and collaborations related to the radiation therapy and radiopharmaceutical markets are also covered.

Report Synopsis

Report Metrics Details
Base year considered 2023
Forecast period considered 2024-2029
Base year market size $16.1 billion
Market size forecast $31.3 billion
Growth rate CAGR of 12.3% for the forecast period of 2024-2029
Units considered $ Millions
Segments covered Segment, Product Type, Technology Type, Application, Production Method, and Region
Regions covered North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Market Drivers
  • Rising prevalence of cancer and other chronic conditions.
  • Advances in radiation therapy planning and delivery systems and techniques.
  • Increasing demand in developing regions.
  • Focus on early diagnosis and screening.
  • Trend towards precision medicine.
Companies studied
ACCURAY INC.CARDINAL HEALTH
CURIUMELEKTA
GE HEALTHCARELANTHEUS
NOVARTIS AGSIEMENS HEALTHINEERS AG
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Frequently Asked Questions (FAQs)

The global radiation therapy products and radiopharmaceuticals market was estimated to be around $16.1 billion in 2023. The market is projected to reach $31.3 billion in 2029, growing at a CAGR of 12.3% during the forecast period.
An in-depth analysis of the global radiation therapy products and radiopharmaceuticals market, including historical data and market projection on sales by technology type, product type, system type, application, and region.
By application type, the oncology segment is anticipated to dominate the market by the end of 2029.
Therapeutic radiopharmaceuticals is the fastest growing market.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets119Free
Chapter- 1: Executive Summary3Free
Chapter- 2: Market Overview 3Free
Chapter- 3: Market Dynamics 10Free
Chapter- 4: Emerging Technologies and Developments 4Free
Chapter- 5: Market Segmentation Analysis64Free
Chapter- 6: Competitive Intelligence3Free
Chapter- 7: Appendix32Free
Published - Oct-2021| Analyst - BCC Publishing| Code - HLC176D

Report Highlights

The global radiopharmaceuticals and therapeutics market should reach $28.5 billion by 2026 from $18.2 billion in 2021 at a compound annual growth rate (CAGR) of 9.4% for the forecast period of 2021 to 2026.

Report Includes

  • 52 data tables and 72 additional tables
  • An overview of the global market for radiotherapy, radiopharmaceuticals, and nuclear medicines
  • Estimation of the market size and analyses of the global market trends, with data from 2019 to 2020, estimates for 2021, with projection of CAGR through 2026
  • Analysis of new opportunities, challenges, and technological changes within the industry and highlights of the market potential by type, method, technology, application and region
  • Assessment of present and future strategies within the radiopharmaceuticals market, including radiopharmaceuticals for both diagnostic and therapeutic purposes
  • Description of positron emission tomography (PET) and single photon emission computed tomography (SPECT) and discussion of their applications
  • Evaluation of market opportunities for external beam radiation therapy, internal radiation therapy and systemic radiotherapy
  • Detailed analysis of the current market trends and forecast, relevant R&D activities, new products launches and product enhancement in the industry and discussion of regulatory elements that are affecting the future marketplace
  • Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
  • Company profiles of major players in the market, including Accuray Inc., Bayer Pharma AG, Cardinal Health, General Electric Co., Nordion Inc. and Siemens Healthineers AG
Published - Jun-2019| Analyst - Vijay Laxmi| Code - HLC176C

Report Highlights

The global radiopharmaceutical and therapeutics market should reach $22.0 billion by 2023 from $14.1 billion in 2018 at a compound annual growth rate (CAGR) of 9.2% for the period of 2018 to 2023.

Report Includes

  • 94 data tables and 83 additional tables
  • An overview of the global market for radiotherapy, radiopharmaceuticals and nuclear medicines
  • Examination of present and future strategies within the radiopharmaceuticals market, including radiopharmaceuticals for both diagnostic and therapeutic purposes
  • Detailed description of positron emission tomography (PET) and single photon emission computed tomography (SPECT) and discussion of their applications
  • Evaluation of market opportunities for external beam radiation therapy, internal radiation therapy and systemic radiotherapy
  • Coverage of new products launches and product enhancement in the industry
  • Comprehensive company profiles of major players, including Accuray Inc., Bayer Pharma AG, C. R. Bard Inc., Eli Lilly and Company, Navidea Biopharmaceuticals Inc., Siemens Healthcare, and Triad Isotopes Inc.
Published - Jun-2017| Analyst - Neha Maliwal| Code - HLC176B

Report Highlights

The global radiotherapy market was valued at $6.4 billion in 2016. The market should reach $6.8 billion and $9.2 billion in 2017 and 2022, respectively; growing at a compound annual growth rate (CAGR) of 6.4% from 2017 to 2022.

Report Includes

  • An overview of the global market for radiotherapy and related technologies and applications.
  • Analyses of market trends with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022.
  • Discussion of major factors driving the growth for nuclear medicine, including neurological diseases such as Alzheimer's disease, Parkinson's disease, and dementia, and an overall increase in awareness about nuclear medicine.
  • Detailed information concerning major challenges the market faces, including the harmful effects of radiation, the tight required regulation of radioisotopes, and a lack of supply of radioisotopes.
  • Analyses of the diagnostic applications for radiotherapy, such as Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET).
  • Comprehensive company profiles of major players in the industry.
Published - Feb-2015| Analyst - Neha Maliwal| Code - HLC176A

Report Highlights

The radiation therapy market totaled $5.4 billion in 2013 and $5.8 billion in  2014. The market is expected to reach $8.1 billion in 2019, a compound annual growth rate(CAGR) of 6.7%. 

Report Includes

  • An overview of the global market for radiotherapy and related technologies and applications
  • Analyses of market trends, with data from 2013 and 2014, and projections of CAGRs through 2019
  • Discussion of major factors driving the growth for nuclear medicine including neurological diseases such as Alzheimer's disease, Parkinson's disease, and dementia, and an overall increase in awareness about nuclear medicine
  • Detailed information conerning major challenges the market faces including the harmful effects of radiation, the tight required regulation of radioisotopes, and a lack of supply of radioisotopes
  • Analysis of the diagnostic applications for radiotherapy such as Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET)
  • Comprehensive company profiles of major players in the industry.

Related Reports

Artificial Intelligence (AI) in Cancer

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO196B

The global market for artificial intelligence (AI) in cancer is estimated to increase from $2.2 billion in 2024 to reach $6.3 billion by 2029, at a compound annual growth rate (CAGR) of 23.1% from 2024 through 2029.

Theranostics: Global Markets

Published - Aug 2024 | Publisher - BCC Publishing | Code - BIO198B

The global market for theranostics was valued at $3.7 billion in 2023. The market is expected to grow from $4.3 billion in 2024 to $12.7 billion by the end of 2029, at a compound annual growth rate, or CAGR, of 24.0% from 2024 to 2029.

Monoclonal Antibodies for Oncology: Global Markets

Published - Jul 2022 | Publisher - BCC Publishing | Code - PHM261A

The global market for monoclonal antibodies in oncology is estimated to grow from $76.2 billion in 2022 to more than $138.1 billion by 2027, with a compound annual growth rate (CAGR) of 12.6% during the forecast period of 2022-2027.

Global Interventional Oncology Market

Published - Jan 2022 | Publisher - BCC Publishing | Code - PHM258A

The global interventional oncology market should reach $3.1 billion by 2026 from $2.2 billion in 2021 at a compound annual growth rate (CAGR) of 7.0% for the forecast period of 2021 to 2026.

Recent Reports

Conventional and Alternative Pain Treatment Markets

Published - Nov 2024 | Publisher - Partha Sarathi Das | Code - HLC266B

The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.

CRISPR Technology: Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC258C

The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC239C

The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.

Medical Devices: Technologies and Global Markets

Published - Oct 2024 | Publisher - Partha Sarathi Das | Code - HLC170F

The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Point-of-Care Diagnostics: Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC043H

The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.

Top Trending Reports

Single-use Technologies for Biopharmaceuticals: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO099F

The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.

Cell and Gene Therapy Tools, and Reagents: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO208C

The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC239C

The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.

Global Market Opportunities and Competitive Landscape for CDMO

Published - Nov 2024 | Publisher - BCC Publishing | Code - PHM238B

The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.

Medical Devices Industry: Competitive Landscape

Published - Nov 2024 | Publisher - BCC Publishing | Code - MDS010C

The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets
Sample Report